Cargando…
Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple Myeloma
Considerable data indicate post-transplant lenalidomide prolongs progression-free survival and probably survival after an autotransplant for multiple myeloma (MM). However, optimal therapy duration is unknown, controversial and differs in the EU and US. We compared outcomes and cost-effectiveness of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Università Cattolica del Sacro Cuore
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114895/ https://www.ncbi.nlm.nih.gov/pubmed/34007422 http://dx.doi.org/10.4084/MJHID.2021.034 |